ADVANTAGES AND DISADVANTAGES OF WARFARIN AND PRADAXA THERAPY FOR VENOUS THROMBOEMBOLISM
An analysis of complex examination of 110 patients with venous thromboembolism was made. The patients were separated into 2 groups. The first group included 60 patients, who had the start heparin therapy during 7 days with the following 6-month warfarin therapy. Warfarin was substituted by pradaxa (...
Main Authors: | B. S. Sukovatykh, L. N. Belikov, O. F. Savchuk, M. B. Sukovatykh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Pavlov First Saint Petersburg State Medical University
2018-01-01
|
Series: | Вестник хирургии имени И.И. Грекова |
Subjects: | |
Online Access: | https://www.vestnik-grekova.ru/jour/article/view/561 |
Similar Items
-
Dabigatran versus Warfarin for the Treatment of Pediatric Thromboembolism: A Pilot Randomized Trial
by: Aziz Eghbali, et al.
Published: (2020-09-01) -
THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY
by: A. A. Rumyantsev, et al.
Published: (2015-09-01) -
IF FATAL PULMONARY EMBOLISM AND ARTERIAL THROMBOTIC EVENTS ARE TWO FACES OF THE ONE DISEASE?
by: N. I. Sglushkov, et al.
Published: (2016-10-01) -
COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015-09-01) -
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation
by: EL Dolgova, et al.
Published: (2014-12-01)